InnoCentive, Inc., the pioneer in open innovation, crowdsourcing, and prize competitions, today announced a computational Challenge to predict the future progression of disease in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. The DREAM-Phil Bowen ALS Prediction Prize4Life Challenge (or ALS Prediction Prize) is being run by Prize4Life, Inc. in collaboration with The DREAM Project and carries a $25,000 prize for the winning prediction.
The new Prize4Life Challenge is based on the PRO-ACT database, which upon completion will contain clinical data for more than 7,500 ALS patients from completed clinical trials. The entire PRO-ACT database will be available for research purposes by year's end and the ALS Prediction Prize will use a subset of this data. Ultimately, it is expected that the solution resulting from this Challenge will improve disease prediction and lead to more accurate methods of forecasting progression earlier on in the course of the disease.